SpaceX IPO Speculation Fuels Surge in SpaceRelated Stocks and ETFs Metas Two Key Developments Could Stabilize Struggling Stock Fed Minutes Reveal Officials Anticipate Rate Hikes If Iran War Keeps Inflation Elevated Analyst Report Highlights Pinterest Incs Growth Potential and Market Position Kevin Warsh Takes Helm as Fed Chair Amid Trumps Push for Rate Cuts Markets Expect Extended Pause Ouras Smart Ring Gains Global Recognition in Expanding HealthTech Wearable Market AVA Q1 2026 Earnings Earnings Per Share Beat Estimates as Utility Operations Remain Steady IEP Q1 2026 Earnings Massive EPS Miss Amid Operational Challenges EVH Q1 2026 Earnings EPS Surpasses Expectations with 614 Surprise PRS Q1 2026 Earnings Robust EPS Beat of 154 Highlights Operational Strength Amid Stable FixedIncome Performance Aspen Aerogels Inc ASPN Q1 2026 Earnings EPS Misses Estimates Stock Rises on Optimism GSIT Q1 2026 Earnings Narrower Loss Drives Stock Rally LB Pharmaceuticals Inc LBRX Breaks Higher as Volume Picks Up Key Resistance Ahead Eagle Nuclear Energy Warrants NUCLW Surge Over 9 as Trading Activity Intensifies Adamas Trust Senior Notes ADAMH Edge Lower Amidst Consolidation Near Par Enveric Biosciences ENVB Surges 84 as Renewed Buying Interest Emerges GoHealth Inc GOCO Surges 74 as Stock Recovers From Recent Lows WaFd Inc WAFD Q1 2026 Earnings EPS Beats Estimates as Net Interest Margin Holds Steady Presidio Property Trust Q3 2023 Earnings Net Loss Widens as Real Estate Headwinds Persist RILYP Q1 2024 Earnings Preferred Stock Reports Negative EPS Amid No Revenue Estimate ARE Q1 2026 Earnings Massive EPS Surprise Driven by Strong Operational Performance Omada Health Inc OMDA Q1 2026 Earnings Narrowerthanexpected Loss Boosts Investor Sentiment Community Trust Bancorp Inc CTBI Q1 2026 Earnings Strong EPS Beat Driven by Solid Core Performance Consumer Price Index Rises 38 Annually in April Exceeding Expectations and Marking Highest Level Since May 2023 CTO Realty Growth Q1 2026 Earnings Massive EPS Beat Sends Mixed Signals as Stock Edges Lower Aspire Biopharma Faces Sharp Decline Testing Key Support Levels